Description:

USMCI 8214/Z6091: Active Monitoring Measurement Form NCT01167725 Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=865EFDDD-7136-0774-E040-BB89AD43619B

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=865EFDDD-7136-0774-E040-BB89AD43619B

Keywords:
Versions (3) ▾
  1. 8/27/12
  2. 5/23/15
  3. 6/3/15
Uploaded on:

June 3, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

USMCI 8214/Z6091: Active Monitoring Measurement Form NCT01167725

1. Record the target lesions in the same order as recorded at pretreatment (refer to Section 11 of the protocol). 2. Measure target lesions in cm. using longest diameter (one dimension only). 3. Record measurements at scheduled evaluations and progression

Header
Visit
Tumor assessment
Overall Response Status at This Assessment
Was progression determined by Symptomatic Deterioration
Weight loss > 10% of body weight
Worsening of tumor-related symptoms
Decline in performance status of >1 level on ECOG Zubrod scale
Was symptomatic or new ascites with peritoneal cytology positive for malignancy found
Was any small bowel obstruction requiring operation with histologically confirmed malignant obstruction found
Did the patient have measurable disease at baseline
Measurable Disease
cm
Nontarget lesion present
Non-Target Lesion Response Status
Non-measurable Disease
Method of Evaluation

Similar models